永安药业: 上海市锦天城（武汉）律师事务所关于潜江永安药业股份有限公司2024年年度股东会的法律意见书

Group 1 - The legal opinion letter is issued by Shanghai Jintiancheng (Wuhan) Law Firm regarding the 2024 annual general meeting of shareholders of Qianjiang Yong'an Pharmaceutical Co., Ltd. [1][2] - The law firm confirms that it has fulfilled its legal responsibilities and conducted necessary verifications for the meeting, ensuring the accuracy and legality of the conclusions presented in the legal opinion [2][12] - The meeting was convened by the company's board of directors, with the decision made during the sixth meeting of the seventh board on April 28, 2025 [2][5] Group 2 - The notice for the annual general meeting was published on April 29, 2025, detailing the meeting's convenor, date, time, and other relevant information, with more than 20 days' notice given [3][5] - The meeting took place on June 24, 2025, at the company's conference room, presided over by the acting chairman [3][4] - The meeting utilized a combination of on-site and online voting methods, with specific time slots allocated for each [4][6] Group 3 - A total of 561 shareholders and their proxies attended the meeting, representing 76,031,566 shares, which is 26.2953% of the total voting shares [5][6] - The online voting system recorded 548 participants, representing 2,205,550 shares, or 0.7628% of the total voting shares [6][7] - The meeting's agenda included proposals that were within the authority of the shareholders' meeting and consistent with the published notice [7][12] Group 4 - The voting results showed that 78,104,116 shares were in favor of the proposals, accounting for the majority of the valid voting shares [8][12] - Among the minority investors, 12,607,582 shares voted in favor, representing 98.9561% of the valid votes from small shareholders [8][10] - The legal opinion concludes that the meeting's procedures, qualifications of the convenor, attendees, and voting processes comply with relevant laws and regulations, confirming the validity of the voting results [12]